Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 3 out of 30 pages
Exam (elaborations)

New Jersey Pharmacovigilance Data Management Course Exam Questions and Correct Answers | Drug Safety, ICSR Processing, MedDRA, Signal Detection & Data Quality Study Guide

Document preview thumbnail
Preview 3 out of 30 pages

Prepare for the New Jersey Pharmacovigilance Data Management Course Exam with comprehensive exam-style questions and correct answers covering pharmacovigilance data sources, adverse event and ICSR processing, seriousness and expectedness assessment, causality assessment, MedDRA coding, safety databases, data quality, case reconciliation, narrative preparation, aggregate safety reporting, signal detection, risk management, clinical-trial and post-marketing safety data, and regulatory compliance. These areas reflect New Jersey pharmacovigilance coursework emphasizing safety-data capture and assessment, database tools, MedDRA, ICSR and aggregate reporting, signal detection, and U.S./EMA regulatory requirements.

Content preview

New Jersey Pharmacovigilance Data
Management Course Exam Question and
correct answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF

1. What is the primary purpose of pharmacovigilance data management?

A. To increase pharmaceutical sales
B. To ensure safety data are collected, processed, coded, reviewed, and reported accurately
C. To replace clinical trial monitoring
D. To determine drug pricing
Correct Answer: B

Rationale: Pharmacovigilance data management ensures that safety information is accurately
captured, processed, maintained, and made available for appropriate safety evaluation and
regulatory reporting.


2. Which type of report describes an adverse event associated with an individual patient?

A. Aggregate safety report
B. Individual Case Safety Report (ICSR)
C. Annual financial report
D. Manufacturing deviation report

Correct Answer: B

Rationale: An Individual Case Safety Report contains information about a suspected adverse
reaction or event involving an individual patient.



3. Which four elements are generally considered essential for a valid ICSR?
A. Patient, reporter, suspect product, and adverse event
B. Manufacturer, distributor, pharmacist, and hospital


1

,C. Product price, lot number, sales volume, and diagnosis
D. Patient age, insurance, address, and income

Correct Answer: A

Rationale: A valid ICSR generally requires an identifiable patient, identifiable reporter, suspect
medicinal product, and adverse event.



4. What is the purpose of case intake in pharmacovigilance?

A. To approve new medicines
B. To receive and initially document safety information
C. To calculate drug profitability
D. To manufacture clinical supplies

Correct Answer: B

Rationale: Case intake is the initial process through which potential safety information enters
the pharmacovigilance system.



5. Which database is commonly used to manage pharmacovigilance safety cases?

A. Safety database
B. Payroll database
C. Inventory database
D. Customer relationship database

Correct Answer: A

Rationale: A validated safety database is designed to capture, process, track, and retrieve
individual safety case information.



6. What is MedDRA primarily used for?

A. Financial accounting
B. Medical terminology coding
C. Drug manufacturing
D. Clinical laboratory calibration
Correct Answer: B
Rationale: MedDRA is a standardized medical terminology used to code and classify medical
information in regulatory and pharmacovigilance systems.
2

, 7. What does ICSR stand for?

A. International Clinical Safety Regulation
B. Individual Case Safety Report
C. Internal Clinical Study Review
D. Investigational Case Submission Record

Correct Answer: B

Rationale: ICSR stands for Individual Case Safety Report, the standard term for an individual
safety case.



8. Why is duplicate detection important in pharmacovigilance?

A. It reduces drug prices
B. It prevents the same safety case from being counted multiple times
C. It eliminates the need for medical review
D. It replaces regulatory reporting

Correct Answer: B

Rationale: Duplicate cases can distort safety analyses, case counts, signal detection, and
regulatory assessments.



9. Which characteristic is most important when designing pharmacovigilance data
systems?

A. Decorative interface
B. Data integrity
C. Advertising capability
D. Sales functionality

Correct Answer: B
Rationale: Data integrity ensures that safety information remains accurate, complete, consistent,
reliable, and traceable.


10. What does data reconciliation involve?
A. Comparing safety data between relevant sources to identify discrepancies
B. Deleting old cases
3

Document information

Uploaded on
August 15, 2026
Number of pages
30
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$22.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
2
Followers
0
Items
924
Last sold
4 days ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions